IFNL4 genotype influences the rate of HIV-1 seroconversion in men who have sex with men

References

• Suppiah V, Moldovan M, Ahlenstiel G, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet. 2009;41:1100–1104.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Nishida N, Sugiyama M, et al. Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009;41:1105–1109.
   PubMed Web of Science ®Google Scholar
• Prokunina-Olsson L, Muchmore B, Tang W, et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet. 2013;45:164–171.
   PubMed Web of Science ®Google Scholar
• Dominguez-Molina B, Tarancon-Diez L, Hua S, et al. HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers. Clin Infect Dis. 2016;64:ciw833.
   PubMed Web of Science ®Google Scholar
• Kuniholm MH, Strickler HD, Anastos K, et al. Relationship of genotype for HLA B*57 and IFNL4 with disease progression in female HIV controllers. Clin Infect Dis. 2017;65:1243.
   PubMed Web of Science ®Google Scholar
• Machmach K, Abad-Molina C, Romero-Sánchez MC, et al. IFNL4 ss469415590 polymorphism is associated with unfavourable clinical and immunological status in HIV-infected individuals. Clin Microbiol Infect. 2015;21:289.e1–289.e4.
   PubMed Web of Science ®Google Scholar
• Freitas IT, Tinago W, Sawa H, et al. Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4+:CD8+ T-cell ratio in treated HIV-1 infection. AIDS Res Ther. 2020;17:13.
   PubMed Web of Science ®Google Scholar
• Meissner EG, Chung D, Tsao B, et al. IFNL4 Genotype does not associate with CD4 T-cell recovery in people living with human immunodeficiency virus. AIDS Res Hum Retroviruses. 2021;37:184–188.
   PubMed Web of Science ®Google Scholar
• Bibert S, Wojtowicz A, Taffé P, et al. The IFNL3/4 δg variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients. Aids. 2014;28:1885–1889.
   PubMed Web of Science ®Google Scholar
• Martin MP, Qi Y, Goedert JJ, et al. IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection. J Infect Dis. 2010;202:1749–1753.
   PubMed Web of Science ®Google Scholar
• Zaidane I, Wakrim L, Oulad Lahsen A, et al. Interleukin 28B rs12979860 genotype and human immunodeficiency virus type 1: susceptibility, AIDS development and therapeutic outcome. Hum Immunol. 2018;79:70–75.
   PubMed Web of Science ®Google Scholar
• Real LM, Herrero R, Rivero-Juárez A, et al. IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection. Aids. 2015;29:1895–1897.
   PubMed Web of Science ®Google Scholar
• Jõgeda E-L, Avi R, Pauskar M, et al. Association of IFNλ4 rs12979860 Polymorphism with the acquisition of HCV and HIV Infections among people who inject drugs. J Med Virol. 2018;90:1779–1783.
   PubMed Web of Science ®Google Scholar
• Jaimes-Bernal C, Rallón N, Benito JM, et al. A knockout IFNL4 variant is associated with protection from sexually transmitted HIV-1 infection. J Infect Dis. 2019;219:772–776.
   PubMed Web of Science ®Google Scholar
• Flynn NM, Forthal DN, Harro CD, et al. Placebo-Controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J Infect Dis. 2005;191:654–665.
   PubMed Web of Science ®Google Scholar
• Meza G, Expósito A, Royo JLJL, et al. Association of complement C3d receptor 2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 vaccine. Aids. 2020;34:25–32.
   PubMed Web of Science ®Google Scholar
• Mendell NR, Simon GA. A general expression for the variance-covariance matrix of estimates of gene frequency: the effects of departures from Hardy-Weinberg equilibrium. Ann Hum Genet. 1984;48:283–286.
   PubMed Web of Science ®Google Scholar
• Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559–575.
   PubMed Web of Science ®Google Scholar
• Martorell-Marugan J, Toro-Dominguez D, Alarcon-Riquelme ME, et al. MetaGenyo: a web tool for meta-analysis of genetic association studies. BMC Bioinformatics. 2017;18:1–6.
   PubMed Web of Science ®Google Scholar
• Saponi-Cortes JMR, Rivas MD, Calle-Alonso F, et al. IFNL4 genetic variant can predispose to COVID-19. Sci Rep. 2021;11:1–4.
   PubMed Web of Science ®Google Scholar
• Barreiro P, Pineda JA, Rallón N, et al. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy. J Infect Dis. 2011;203:1629–1636.
   PubMed Web of Science ®Google Scholar
• Sato M, Kondo M, Tateishi R, et al. Impact of IL28B genetic variation on HCV-induced liver fibrosis, inflammation, and steatosis: a meta-analysis. PLoS One. 2014;9.
   Web of Science ®Google Scholar
• Prokunina-Olsson L. Genetics of the human interferon lambda region. J Interf Cytokine Res. 2019;39:599–608.
   PubMed Web of Science ®Google Scholar
• Obajemu AA, Rao N, Dilley KA, et al. IFN-λ4 attenuates antiviral responses by enhancing negative regulation of IFN signaling. J Immunol. 2017;199:3808–3820.
   PubMed Web of Science ®Google Scholar
• Chowdhuri S, Badr MS. Control of ventilation in health and disease. Chest. 2017;151:917–929.
   PubMed Web of Science ®Google Scholar
• Crow YJ. Type I interferonopathies: mendelian type I interferon up-regulation. Curr Opin Immunol. 2015;32:7–12.
   PubMed Web of Science ®Google Scholar
• Fan W, Xie S, Zhao X, et al. IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis C through long-term induction of USP18. J Gen Virol. 2016;97:2210–2220.
   PubMed Web of Science ®Google Scholar